Growth/Differentiation Factor 8 Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: G32F32E1AAB8EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Growth/Differentiation Factor 8 in Global, including the following market information:

Global Growth/Differentiation Factor 8 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Growth/Differentiation Factor 8 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

OSX-200 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Growth/Differentiation Factor 8 include Acceleron Pharma, Inc., Atara Biotherapeutics, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Milo Biotechnology LLC, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sarepta Therapeutics, Inc. and Scholar Rock, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Growth/Differentiation Factor 8 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Growth/Differentiation Factor 8 Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Growth/Differentiation Factor 8 Market Segment Percentages, by Type, 2021 (%)

• OSX-200
• SRK-015
• ACE-2494
• ACE-2798
• BMS-986089
• Others

Global Growth/Differentiation Factor 8 Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Growth/Differentiation Factor 8 Market Segment Percentages, by Application, 2021 (%)

• Becker Muscular Dystrophy
• Fibrosis
• Myelofibrosis
• Sickle Cell Disease
• Others

Global Growth/Differentiation Factor 8 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Growth/Differentiation Factor 8 Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Growth/Differentiation Factor 8 revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Growth/Differentiation Factor 8 revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Acceleron Pharma, Inc.
• Atara Biotherapeutics, Inc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Milo Biotechnology LLC
• Pfizer Inc.
• Regeneron Pharmaceuticals, Inc.
• Sarepta Therapeutics, Inc.
• Scholar Rock, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Growth/Differentiation Factor 8 Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Growth/Differentiation Factor 8 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GROWTH/DIFFERENTIATION FACTOR 8 OVERALL MARKET SIZE

2.1 Global Growth/Differentiation Factor 8 Market Size: 2021 VS 2028
2.2 Global Growth/Differentiation Factor 8 Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Growth/Differentiation Factor 8 Players in Global Market
3.2 Top Global Growth/Differentiation Factor 8 Companies Ranked by Revenue
3.3 Global Growth/Differentiation Factor 8 Revenue by Companies
3.4 Top 3 and Top 5 Growth/Differentiation Factor 8 Companies in Global Market, by Revenue in 2021
3.5 Global Companies Growth/Differentiation Factor 8 Product Type
3.6 Tier 1, Tier 2 and Tier 3 Growth/Differentiation Factor 8 Players in Global Market
  3.6.1 List of Global Tier 1 Growth/Differentiation Factor 8 Companies
  3.6.2 List of Global Tier 2 and Tier 3 Growth/Differentiation Factor 8 Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Growth/Differentiation Factor 8 Market Size Markets, 2021 & 2028
  4.1.2 OSX-200
  4.1.3 SRK-015
  4.1.4 ACE-2494
  4.1.5 ACE-2798
  4.1.6 BMS-986089
  4.1.7 Others
4.2 By Type - Global Growth/Differentiation Factor 8 Revenue & Forecasts
  4.2.1 By Type - Global Growth/Differentiation Factor 8 Revenue, 2017-2022
  4.2.2 By Type - Global Growth/Differentiation Factor 8 Revenue, 2023-2028
  4.2.3 By Type - Global Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Growth/Differentiation Factor 8 Market Size, 2021 & 2028
  5.1.2 Becker Muscular Dystrophy
  5.1.3 Fibrosis
  5.1.4 Myelofibrosis
  5.1.5 Sickle Cell Disease
  5.1.6 Others
5.2 By Application - Global Growth/Differentiation Factor 8 Revenue & Forecasts
  5.2.1 By Application - Global Growth/Differentiation Factor 8 Revenue, 2017-2022
  5.2.2 By Application - Global Growth/Differentiation Factor 8 Revenue, 2023-2028
  5.2.3 By Application - Global Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Growth/Differentiation Factor 8 Market Size, 2021 & 2028
6.2 By Region - Global Growth/Differentiation Factor 8 Revenue & Forecasts
  6.2.1 By Region - Global Growth/Differentiation Factor 8 Revenue, 2017-2022
  6.2.2 By Region - Global Growth/Differentiation Factor 8 Revenue, 2023-2028
  6.2.3 By Region - Global Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Growth/Differentiation Factor 8 Revenue, 2017-2028
  6.3.2 US Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.3.3 Canada Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.3.4 Mexico Growth/Differentiation Factor 8 Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Growth/Differentiation Factor 8 Revenue, 2017-2028
  6.4.2 Germany Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.4.3 France Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.4.4 U.K. Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.4.5 Italy Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.4.6 Russia Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.4.7 Nordic Countries Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.4.8 Benelux Growth/Differentiation Factor 8 Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Growth/Differentiation Factor 8 Revenue, 2017-2028
  6.5.2 China Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.5.3 Japan Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.5.4 South Korea Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.5.5 Southeast Asia Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.5.6 India Growth/Differentiation Factor 8 Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Growth/Differentiation Factor 8 Revenue, 2017-2028
  6.6.2 Brazil Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.6.3 Argentina Growth/Differentiation Factor 8 Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Growth/Differentiation Factor 8 Revenue, 2017-2028
  6.7.2 Turkey Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.7.3 Israel Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.7.4 Saudi Arabia Growth/Differentiation Factor 8 Market Size, 2017-2028
  6.7.5 UAE Growth/Differentiation Factor 8 Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Acceleron Pharma, Inc.
  7.1.1 Acceleron Pharma, Inc. Corporate Summary
  7.1.2 Acceleron Pharma, Inc. Business Overview
  7.1.3 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Major Product Offerings
  7.1.4 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.1.5 Acceleron Pharma, Inc. Key News
7.2 Atara Biotherapeutics, Inc.
  7.2.1 Atara Biotherapeutics, Inc. Corporate Summary
  7.2.2 Atara Biotherapeutics, Inc. Business Overview
  7.2.3 Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Major Product Offerings
  7.2.4 Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.2.5 Atara Biotherapeutics, Inc. Key News
7.3 Bristol-Myers Squibb Company
  7.3.1 Bristol-Myers Squibb Company Corporate Summary
  7.3.2 Bristol-Myers Squibb Company Business Overview
  7.3.3 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Major Product Offerings
  7.3.4 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Company Key News
7.4 Eli Lilly and Company
  7.4.1 Eli Lilly and Company Corporate Summary
  7.4.2 Eli Lilly and Company Business Overview
  7.4.3 Eli Lilly and Company Growth/Differentiation Factor 8 Major Product Offerings
  7.4.4 Eli Lilly and Company Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly and Company Key News
7.5 Milo Biotechnology LLC
  7.5.1 Milo Biotechnology LLC Corporate Summary
  7.5.2 Milo Biotechnology LLC Business Overview
  7.5.3 Milo Biotechnology LLC Growth/Differentiation Factor 8 Major Product Offerings
  7.5.4 Milo Biotechnology LLC Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.5.5 Milo Biotechnology LLC Key News
7.6 Pfizer Inc.
  7.6.1 Pfizer Inc. Corporate Summary
  7.6.2 Pfizer Inc. Business Overview
  7.6.3 Pfizer Inc. Growth/Differentiation Factor 8 Major Product Offerings
  7.6.4 Pfizer Inc. Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Inc. Key News
7.7 Regeneron Pharmaceuticals, Inc.
  7.7.1 Regeneron Pharmaceuticals, Inc. Corporate Summary
  7.7.2 Regeneron Pharmaceuticals, Inc. Business Overview
  7.7.3 Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Major Product Offerings
  7.7.4 Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.7.5 Regeneron Pharmaceuticals, Inc. Key News
7.8 Sarepta Therapeutics, Inc.
  7.8.1 Sarepta Therapeutics, Inc. Corporate Summary
  7.8.2 Sarepta Therapeutics, Inc. Business Overview
  7.8.3 Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Major Product Offerings
  7.8.4 Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.8.5 Sarepta Therapeutics, Inc. Key News
7.9 Scholar Rock, Inc.
  7.9.1 Scholar Rock, Inc. Corporate Summary
  7.9.2 Scholar Rock, Inc. Business Overview
  7.9.3 Scholar Rock, Inc. Growth/Differentiation Factor 8 Major Product Offerings
  7.9.4 Scholar Rock, Inc. Growth/Differentiation Factor 8 Revenue in Global Market (2017-2022)
  7.9.5 Scholar Rock, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Growth/Differentiation Factor 8 Market Opportunities & Trends in Global Market
Table 2. Growth/Differentiation Factor 8 Market Drivers in Global Market
Table 3. Growth/Differentiation Factor 8 Market Restraints in Global Market
Table 4. Key Players of Growth/Differentiation Factor 8 in Global Market
Table 5. Top Growth/Differentiation Factor 8 Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Growth/Differentiation Factor 8 Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Growth/Differentiation Factor 8 Revenue Share by Companies, 2017-2022
Table 8. Global Companies Growth/Differentiation Factor 8 Product Type
Table 9. List of Global Tier 1 Growth/Differentiation Factor 8 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Growth/Differentiation Factor 8 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Growth/Differentiation Factor 8 Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Growth/Differentiation Factor 8 Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Growth/Differentiation Factor 8 Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Growth/Differentiation Factor 8 Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Growth/Differentiation Factor 8 Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Growth/Differentiation Factor 8 Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2023-2028
Table 30. Acceleron Pharma, Inc. Corporate Summary
Table 31. Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Product Offerings
Table 32. Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)
Table 33. Atara Biotherapeutics, Inc. Corporate Summary
Table 34. Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Product Offerings
Table 35. Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Company Corporate Summary
Table 37. Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Product Offerings
Table 38. Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly and Company Corporate Summary
Table 40. Eli Lilly and Company Growth/Differentiation Factor 8 Product Offerings
Table 41. Eli Lilly and Company Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)
Table 42. Milo Biotechnology LLC Corporate Summary
Table 43. Milo Biotechnology LLC Growth/Differentiation Factor 8 Product Offerings
Table 44. Milo Biotechnology LLC Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Inc. Corporate Summary
Table 46. Pfizer Inc. Growth/Differentiation Factor 8 Product Offerings
Table 47. Pfizer Inc. Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)
Table 48. Regeneron Pharmaceuticals, Inc. Corporate Summary
Table 49. Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Product Offerings
Table 50. Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)
Table 51. Sarepta Therapeutics, Inc. Corporate Summary
Table 52. Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Product Offerings
Table 53. Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)
Table 54. Scholar Rock, Inc. Corporate Summary
Table 55. Scholar Rock, Inc. Growth/Differentiation Factor 8 Product Offerings
Table 56. Scholar Rock, Inc. Growth/Differentiation Factor 8 Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Growth/Differentiation Factor 8 Segment by Type in 2021
Figure 2. Growth/Differentiation Factor 8 Segment by Application in 2021
Figure 3. Global Growth/Differentiation Factor 8 Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Growth/Differentiation Factor 8 Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Growth/Differentiation Factor 8 Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Growth/Differentiation Factor 8 Revenue in 2021
Figure 8. By Type - Global Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
Figure 9. By Application - Global Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
Figure 10. By Region - Global Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
Figure 11. By Country - North America Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
Figure 12. US Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
Figure 16. Germany Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 17. France Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
Figure 24. China Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 28. India Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
Figure 30. Brazil Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Growth/Differentiation Factor 8 Revenue Market Share, 2017-2028
Figure 33. Turkey Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Growth/Differentiation Factor 8 Revenue, (US$, Mn), 2017-2028
Figure 37. Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly and Company Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Milo Biotechnology LLC Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Inc. Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Scholar Rock, Inc. Growth/Differentiation Factor 8 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)